| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.24 | 6e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.24 | 7e-07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.083 | 0.1 |